Aim: To evaluate the effect of Phaco Chop Cataract Surgery on Corneal Endothelium. Setting: Kasr Al-Ainy, university hospital, in the period between Aug-2021 to Feb-2022. Methods: A prospective study included 30-eyes that underwent cataract surgery using Phacochop technique. Endothelial cell loss (ECL) was correlated to effective phaco-time in seconds (EPT), age of the patients, and their gender 3-months postoperatively using specular microscopy. Results: This study was performed on 30 patients (17-cases were males, and 13-cases were females) who underwent phacoemulsification. Their ages ranged from 55 to 80 years, with a mean of 66.5 (± 6.54) years. The mean preoperative cell density (CD)was 2236 cell/mm 2 , that decreased to 1597 cells/mm 2 , 3-months postoperatively. This drop in CD was statistically significant (p<0.001). There was a significant positive correlation (P<0.0001) between ECL and EPT. Also, there was a significant positive correlation (P<0.0001) between EPT and cataract density. However, there was no correlation (P=0.9316) between ECL and age. Also, there was no correlation between ECL and gender (P = 0.326). There was significant improvement of visual acuity in all cases (P < 0.0001). Conclusion: Phaco Chop is an effective technique for cataract surgery. However, there was a significant effect on corneal endothelium.ECL was related EPT, which in turn was related type of senile cataract.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.